Pathophysiology of Peripheral Artery Disease, Intermittent Claudication, and Critical Limb Ischemia

Vascular Medicine: A Companion to Braunwald's Heart Disease: Second Edition

Volumn , Issue , 2013, Pages 223-230

  Hiatt, William R ^a   Brass, Eric P ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928161608     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2930-6.00017-3     Document Type: Chapter

References (117)

1. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
2. Pande R.L., Perlstein T.S., Beckman J.A., et al. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011, 124:17-23.
3. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
4. Rocha V.Z., Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009, 6:399-409.
5. Dachun X., Jue L., Liling Z., et al. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vasc Med 2010, 15:361-369.
6. Bauer T.A., Regensteiner J.G., Brass E.P., et al. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol 1999, 87:809-816.
7. McDermott M.M., Greenland P., Liu K., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001, 286:1599-1606.
8. McDermott M.M., Mehta S., Liu K., et al. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med 1999, 14:173-181.
9. Vogt M.T., Cauley J.A., Kuller L.H., et al. Functional status and mobility among elderly women with lower extremity arterial disease: the study of osteoporotic fractures. J Am Geriatr Soc 1994, 42:923-929.
10. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208.
11. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al: ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation, J Am Coll Cardiol 47:1239-1312, 2006.
12. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007, 45:S5-S67.
13. Sigvant B., Wiberg-Hedman K., Bergqvist D., et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007, 45:1185-1191.
14. Dormandy J., Mahir M., Ascady G., et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989, 30:50-57.
15. Belch J., Hiatt W.R., Baumgartner I., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377:1929-1937.
16. Gray B.H., Grant A.A., Kalbaugh C.A., et al. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg 2010, 24:349-359.
17. Faglia E., Clerici G., Clerissi J., et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009, 32:822-827.
18. Van B.E., Nikol S., Norgren L., et al. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2011, 42:365-373.
19. Gardner A.W., Montgomery P.S. Resting energy expenditure in patients with intermittent claudication and critical limb ischemia. J Vasc Surg 2010, 51:1436-1441.
20. Richardson R.S., Grassi B., Gavin T.P., et al. Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps. J Appl Physiol 1999, 86:1048-1053.
21. Richardson R.S., Leigh J.S., Wagner P.D., et al. Cellular PO2 as a determinant of maximal mitochondrial O(2) consumption in trained human skeletal muscle. J Appl Physiol 1999, 87:325-331.
22. Grassi B., Pogliaghi S., Rampichini S., et al. Muscle oxygenation and pulmonary gas exchange kinetics during cycling exercise on-transitions in humans. J Appl Physiol 2003, 95:149-158.
23. Young D.F., Tsai F.Y. Flow characteristics in models of arterial stenoses. II. Unsteady flow. J Biomech 1973, 6:547-559.
24. Flanigan D.P., Tullis J.P., Streeter V.L., et al. Multiple subcritical arterial stenoses: effect on poststenotic pressure and flow. Ann Surg 1977, 186:663-668.
25. Karayannacos P.E., Talukder N., Nerem R.M., et al. The role of multiple noncritical arterial stenoses in the pathogenesis of ischemia. J Thorac Cardiovasc Surg 1977, 73:458-469.
26. Young D.F., Cholvin N.R., Kirkeeide R.L., et al. Hemodynamics of arterial stenoses at elevated flow rates. Circ Res 1977, 41:99-107.
27. Demer L., Gould K.L., Kirkeeide R. Assessing stenosis severity: coronary flow reserve, collateral function, quantitative coronary arteriography, positron imaging, and digital subtraction angiography. A review and analysis. Prog Cardiovasc Dis 1988, 30:307-322.
28. Lewis P., Psaila J.V., Morgan R.H., et al. Common femoral artery volume flow in peripheral vascular disease. Br J Surg 1990, 77:183-187.
29. Park S.J., Ahn J.M., Kang S.J. Paradigm shift to functional angioplasty: new insights for fractional flow reserve- and intravascular ultrasound-guided percutaneous coronary intervention. Circulation 2011, 124:951-957.
30. Pijls N.H., Van Gelder B., Van der Voort P., et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995, 92:3183-3193.
31. Pentecost B.L. The effect of exercise on the external iliac vein blood flow and local oxygen consumption in normal subjects, and in those with occlusive arterial disease. Clin Sci 1964, 27:437-445.
32. Hillestad LK: The peripheral blood flow in intermittent claudication IV. The significance of the claudication distance, Acta Med Scand 173:467-478, 1963.
33. Bauer T.A., Brass E.P., Hiatt W.R. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 2004, 40:488-493.
34. Sumner D.S., Strandness D.E. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication. Surgery 1969, 65:763-771.
35. Maass U., Alexander K. Effect of treadmill exercise on blood gases and acid-base balance in patients with intermittent claudication. Z Kardiol 1983, 72:537-542.
36. Hansen J.E., Sue D.Y., Oren A., et al. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol 1987, 59:669-674.
37. Szuba A., Oka R.K., Harada R., et al. Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 2006, 11:155-163.
38. Gardner A.W., Ricci M.A., Case T.D., et al. Practical equations to predict claudication pain distances from a graded treadmill test. Vasc Med 1996, 1:91-96.
39. Gardner A.W., Skinner J.S., Cantwell B.W., et al. Prediction of claudication pain from clinical measurements obtained at rest. Med Sci Sports Exerc 1992, 24:163-170.
40. Gordon M.B., Jain R., Beckman J.A., et al. The contribution of nitric oxide to exercise hyperemia in the human forearm. Vasc Med 2002, 7:163-168.
41. Kinlay S., Creager M.A., Fukumoto M., et al. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001, 38:1049-1053.
42. Boushel R., Langberg H., Gemmer C., et al. Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise. J Physiol 2002, 543:691-698.
43. Anderson T.J., Gerhard M.D., Meredith I.T., et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995, 75:71B-74B.
44. Tsao P.S., Buitrago R., Chang H., et al. Effects of diabetes on monocyte-endothelial interactions and endothelial superoxide production in fructose-induced insulin-resistant and hypertensive rats. Circulation 1995, 92:A2666.
45. Liao J.K., Bettmann M.A., Sandor T., et al. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res 1991, 68:1027-1034.
46. Newton D.J., Khan F., Kennedy G., et al. Improvement in systemic endothelial condition following amputation in patients with critical limb ischemia. Int Angiol 2008, 27:408-412.
47. Woodburn K.R., Lowe G.D., Rumley A., et al. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995, 14:346-352.
48. Dormandy J.A., Hoare E., Colley J., et al. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 1973, 4:576-581.
49. Reid H.L., Dormandy J.A., Barnes A.J., et al. Impaired red cell deformability in peripheral vascular disease. Lancet 1976, 1:666-668.
50. Holmberg A., Sandhagen B., Bergqvist D. Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction. J Vasc Surg 2000, 31:691-695.
51. Nash G.B., Thomas P.R., Dormandy J.A. Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg. Br Med J (Clin Res Ed) 1988, 296:1699-1701.
52. Belch J.J., Sohngen M., Robb R., et al. Neutrophil count and amputation in critical limb ischaemia. Int Angiol 1999, 18:140-144.
53. Anderson S.I., Shiner R., Brown M.D., et al. ICAM-1 expression and leukocyte behavior in the microcirculation of chronically ischemic rat skeletal muscles. Microvasc Res 2006, 71:205-211.
54. Cassar K., Bachoo P., Ford I., et al. Platelet activation is increased in peripheral arterial disease. J Vasc Surg 2003, 38:99-103.
55. Jarajapu Y.P., Coats P., McGrath J.C., et al. Increased alpha(1)- and alpha(2)-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia. Cardiovasc Res 2001, 49:218-225.
56. Coats P., Hillier C. Differential responses in human subcutaneous and skeletal muscle vascular beds to critical limb ischaemia. Eur J Vasc Endovasc Surg 2000, 19:387-395.
57. Jarajapu Y.P., McGrath J.C., Hillier C., et al. The alpha 1-adrenoceptor profile in human skeletal muscle resistance arteries in critical limb ischaemia. Cardiovasc Res 2003, 57:554-562.
58. Tsui J.C., Baker D.M., Biecker E., et al. Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in man. Eur J Vasc Endovasc Surg 2003, 25:443-450.
59. Jacobs M.J., Ubbink D.T., Kitslaar P.J., et al. Assessment of the microcirculation provides additional information in critical limb ischaemia. Eur J Vasc Surg 1992, 6:135-141.
60. Anvar M.D., Khiabani H.Z., Kroese A.J., et al. Alterations in capillary permeability in the lower limb of patients with chronic critical limb ischaemia and oedema. Vasa 2000, 29:106-111.
61. Coats P., Wadsworth R. Marriage of resistance and conduit arteries breeds critical limb ischemia. Am J Physiol Heart Circ Physiol 2005, 288:H1044-H1050.
62. Edwards A.T., Blann A.D., Suarez-Mendez V.J., et al. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 1994, 81:1738-1741.
63. Belch J.J., McLaren M., Khan F., et al. The inflammatory process in intermittent claudication. Eur Heart J 2002, 4:B31-B34.
64. Belch J.J., Mackay I.R., Hill A., et al. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol 1995, 14:385-388.
65. Brevetti G., De Caterina M., Martone V.D., et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 2001, 24:193-199.
66. Signorelli S.S., Mazzarino M.C., Di Pino L., et al. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 2003, 8:15-19.
67. Blann A.D., Dobrotova M., Kubisz P., et al. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995, 74:626-630.
68. Neumann F.J., Waas W., Diehm C., et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation 1990, 82:922-929.
69. Paul B.Z., Jin J., Kunapuli S.P. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999, 274:29108-29114.
70. Kirkpatrick U.J., Mossa M., Blann A.D., et al. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost 1997, 78:1338-1342.
71. Cassar K., Bachoo P., Ford I., et al. Platelet activation is increased in peripheral arterial disease. J Vasc Surg 2003, 38:99-103.
72. Hope S.A., Meredith I.T. Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J 2003, 33:380-386.
73. Mehta J., Dinerman J., Mehta P., et al. Neutrophil function in ischemic heart disease. Circulation 1989, 79:549-556.
74. Lowe G.D.O., Fowkes F.G.R., Dawes J., et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993, 87:1915-1920.
75. Turton E.P., Coughlin P.A., Kester R.C., et al. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg 2002, 23:309-316.
76. Karmazyn M. Ischemic and reperfusion injury in the heart: cellular mechanisms and pharmacologic interventions. Can J Physiol Pharmacol 1991, 69:719-730.
77. Turrens J.F., Beconi M., Barilla J., et al. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun 1991, 12-13(Pt 2):681-689.
78. Kemp G.J., Roberts N., Bimson W.E., et al. Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg 2001, 34:1103-1110.
79. Hickman P., Harrison D.K., Hill A., et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol 1994, 361:565-570.
80. Ciuffetti G., Mercuri M., Mannarino E., et al. Free radical production in peripheral vascular disease. A risk for critical ischaemia?. Int Angiol 1991, 10:81-87.
81. Melov S., Shoffner J.M., Kaufman A., et al. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res 1995, 23:4122-4126.
82. Bhat H.K., Hiatt W.R., Hoppel C.L., et al. Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation 1999, 99:807-812.
83. Rouslin W., Ranganathan S. Impaired function of mitochondrial electron transfer complex I in canine myocardial ischemia: loss of flavin mononucleotide. J Mol Cell Cardiol 1983, 15:537-542.
84. Kumar D., Jugdutt B.I. Apoptosis and oxidants in the heart. J Lab Clin Med 2003, 142:288-297.
85. Sastre J., Pallardo F.V., Vina J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003, 35:1-8.
86. Ting H.H., Timimi F.K., Boles K.S., et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22-28.
87. Kinlay S., Behrendt D., Fang J.C., et al. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 2004, 43:629-634.
88. Nanobashvili J., Neumayer C., Fuegl A., et al. Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle. J Vasc Surg 2004, 39:868-877.
89. Regensteiner J.G., Wolfel E.E., Brass E.P., et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 1993, 87:413-421.
90. Steinacker J.M., Opitz-Gress A., Baur S., et al. Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease. J Vasc Surg 2000, 31:443-449.
91. Askew C.D., Green S., Walker P.J., et al. Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease. J Vasc Surg 2005, 41:802-807.
92. McGuigan M.R., Bronks R., Newton R.U., et al. Muscle fiber characteristics in patients with peripheral arterial disease. Med Sci Sports Exerc 2001, 33:2016-2021.
93. Mitchell R.G., Duscha B.D., Robbins J.L., et al. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med 2007, 12:285-290.
94. Goodman M.N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991, 260:E727-E730.
95. Goodman M.N. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994, 205:182-185.
96. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002, 57:M326-M332.
97. Meadows K.A., Holly J.M., Stewart C.E. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol 2000, 183:330-337.
98. McDermott M.M., Ferrucci L., Guralnik J.M., et al. Elevated levels of inflammation, D-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol 2007, 50:897-905.
99. England J.D., Ferguson M.A., Hiatt W.R., et al. Progression of neuropathy in peripheral arterial disease. Muscle Nerve 1995, 18:380-387.
100. Laghi P.F., Pastorelli M., Beermann U., et al. Peripheral neuropathy associated with ischemic vascular disease of the lower limbs. Angiology 1996, 47:569-577.
101. Weinberg D.H., Simovic D., Isner J., et al. Chronic ischemic monomelic neuropathy from critical limb ischemia. Neurology 2001, 57:1008-1012.
102. McGuigan M.R., Bronks R., Newton R.U., et al. Muscle fiber characteristics in patients with peripheral arterial disease. Med Sci Sports Exerc 2001, 33:2016-2021.
103. Sala E., Noyszewski E.A., Campistol J.M., et al. Impaired muscle oxygen transfer in patients with chronic renal failure. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1240-R1248.
104. Scherer S.A., Bainbridge J.S., Hiatt W.R., et al. Gait characteristics of patients with claudication. Arch Phys Med Rehabil 1998, 79:529-531.
105. Scherer S.A., Hiatt W.R., Regensteiner J.G. Lack of relationship between gait parameters and physical function in peripheral arterial disease. J Vasc Surg 2006, 44:782-788.
106. Bauer T.A., Brass E.P., Barstow T.J., et al. Skeletal muscle StO(2) kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol 2007, 100:143-151.
107. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol 1983, 244:H743-H748.
108. Brass E.P., Hiatt W.R., Gardner A.W., et al. Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. Am J Physiol 2001, 280:H603-H609.
109. Kemp G.J., Taylor D.J., Thompson C.H., et al. Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 1993, 6:302-310.
110. Wibom R., Hultman E., Johansson M., et al. Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol 1992, 73:2004-2010.
111. Wang H., Hiatt W.R., Barstow T.J., et al. Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: Alterations with disease. Eur J Appl Physiol 1999, 80:22-27.
112. Lundgren F., Dahllof A.G., Schersten T., et al. Muscle enzyme adaptation in patients with peripheral arterial insufficiency: Spontaneous adaptation, effect of different treatments and consequences on walking performance. Clin Sci 1989, 77:485-493.
113. Hiatt W.R., Regensteiner J.G., Wolfel E.E., et al. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 1996, 81:780-788.
114. Jansson E., Johansson J., Sylven C., et al. Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol 1988, 8:17-29.
115. Brass E.P., Hoppel C.L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J 1980, 190:495-504.
116. Hiatt W.R., Nawaz D., Brass E.P. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol 1987, 62:2383-2387.
117. Hiatt W.R., Wolfel E.E., Regensteiner J.G., et al. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 1992, 73:346-353.